BPTF and lung cancer: In a previous study, our group identified the first BPTF bromodomain inhibitor, C620-0696, through protein expression abnormalities in the epigenetic dimension of lung cancer, and demonstrated its ability to inhibit the proliferation and migration of lung cancer cells [48].